• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Kura Oncology, Inc. - Common Stock (NQ:KURA)

    9.840 -0.290 (-2.86%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Kura Oncology, Inc. - Common Stock

    < Previous 1 2 3 4 5 Next >
    MicroVision, RadNet And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. MicroVision, Inc. (NASDAQ: MVIS) shares dropped 12.7% to $5.56 in... 
    Via Benzinga
    Analyst Ratings for Kura Oncology
     
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2023
     
    Via Benzinga
    Kura Oncology: Q1 Earnings Insights
     
    Via Benzinga
    3 Under-the-Radar Stocks That AI Predicts Will Soar in May
    We enlisted the support of the generative AI chatbot that powers Bing chat to find under-the-radar stocks to buy 
    Via InvestorPlace
    Kura Oncology's Earnings Outlook
     
    Via Benzinga
    Kura Oncology Shares Fall After Updated Ziftomenib Data At ASH Meeting
     
    Via Benzinga
    Kura Oncology Reports Preliminary Proof Of Mechanism Data From Early-Stage In Head & Neck Cancer
     
    Via Benzinga
    First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    7 Undiscovered Stocks to Watch for the Next Big Thing
    If you have a tolerance for risk and are willing to look for hot stocks to trade, here are some to the top stocks to watch. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023
     
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
     
    Via Benzinga
    Read Why Did Credit Suisse Raise Price Target On Kura Oncology
     
    Via Benzinga
    Why Kura Oncology Stock Is Moving Higher Tuesday Morning
    Kura Oncology Inc (NASDAQ: KURA) shares are trading higher Tuesday after the company announced the FDA clearance of its Inve 
    Via Benzinga
    Cramer Is Holding This Biotech Stock
    On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutical Inc (NASDAQ: BMRN). 
    Via Benzinga
    RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
    U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    Preview: Kura Oncology's Earnings
    Kura Oncology (NASDAQ:KURA) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Kura Oncology... 
    Via Benzinga
    Kura Oncology Stock Shows Improved Relative Strength; Still Shy Of Benchmark
    In a welcome move, Kura Oncology stock saw its Relative Strength Rating improve from 69 to 75 on Wednesday. 
    Via Investor's Business Daily
    Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
    Gainers 
    Via Benzinga
    Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday
    U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Kura Oncology Stock Joins Rank Of Stocks With RS Ratings Over 90
    On Monday, Kura Oncology stock had its Relative Strength (RS) Rating upgraded to 91, up from 85 a day earlier. 
    Via Investor's Business Daily
    7 Cheap Biotech Stocks to Buy Now
    These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector. 
    Via InvestorPlace
    Earnings Preview: Kura Oncology
    Kura Oncology (NASDAQ:KURA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that Kura... 
    Via Benzinga
    Kura Oncology Stock Scores Rising Relative Strength
    On Thursday, Kura Oncology stock had its Relative Strength (RS) Rating stock upgraded to 93 from 81 a day earlier. 
    Via Investor's Business Daily
    Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
    Upgrades 
    Via Benzinga
    PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst
    Biotechnology is one sector that peaked ahead of the S&P 500 index. While the S&P 500 index did not peak until January, the SPDR Biotech (NYSE: XBI) peaked in February 2021 and is now 60% lower than... 
    Via Benzinga
    The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal 
    Via Benzinga
    The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
    Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion. 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.